| Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome CJ Lessard, H Li, I Adrianto, JA Ice, A Rasmussen, KM Grundahl, JA Kelly, ... Nature genetics 45 (11), 1284-1292, 2013 | 578 | 2013 |
| Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase … R Fleischmann, E Mysler, S Hall, AJ Kivitz, RJ Moots, Z Luo, R DeMasi, ... The Lancet 390 (10093), 457-468, 2017 | 513 | 2017 |
| Three multicenter, randomized, double‐blind, placebo‐controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis A Deodhar, LS Gensler, J Sieper, M Clark, C Calderon, Y Wang, Y Zhou, ... Arthritis & Rheumatology 71 (2), 258-270, 2019 | 333 | 2019 |
| Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome SA Waterman, TP Gordon, M Rischmueller Arthritis & Rheumatism: Official Journal of the American College of …, 2000 | 323 | 2000 |
| Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double‐blind, placebo‐controlled, dose‐escalating, single‐and repeated‐dose study PP Tak, RM Thurlings, C Rossier, I Nestorov, A Dimic, V Mircetic, ... Arthritis & Rheumatism 58 (1), 61-72, 2008 | 267 | 2008 |
| Trial of upadacitinib or abatacept in rheumatoid arthritis A Rubbert-Roth, J Enejosa, AL Pangan, B Haraoui, M Rischmueller, ... New England Journal of Medicine 383 (16), 1511-1521, 2020 | 250 | 2020 |
| Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data … P Brito-Zerón, N Acar-Denizli, M Zeher, A Rasmussen, R Seror, ... Annals of the rheumatic diseases 76 (6), 1042-1050, 2017 | 215 | 2017 |
| How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project) P Brito-Zerón, N Acar-Denizli, WF Ng, M Zeher, A Rasmussen, T Mandl, ... Clinical and experimental rheumatology 36 (3), S102-S112, 2018 | 200 | 2018 |
| Efficacy and safety of upadacitinib monotherapy in methotrexate‐naive patients with moderately‐to‐severely active rheumatoid arthritis (SELECT‐EARLY): a multicenter, multi … R van Vollenhoven, T Takeuchi, AL Pangan, A Friedman, MEF Mohamed, ... Arthritis & Rheumatology 72 (10), 1607-1620, 2020 | 194 | 2020 |
| Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex … SR Burrows, SL Silins, R Khanna, JM Burrows, M Rischmueller, ... European journal of immunology 27 (7), 1726-1736, 1997 | 185 | 1997 |
| Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use SM Proudman, MJ James, LD Spargo, RG Metcalf, TR Sullivan, ... Annals of the rheumatic diseases 74 (1), 89-95, 2015 | 180 | 2015 |
| X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47, XXX in systemic lupus erythematosus and Sjögren's syndrome K Liu, BT Kurien, SL Zimmerman, KM Kaufman, DH Taft, LC Kottyan, ... Arthritis & Rheumatology 68 (5), 1290-1300, 2016 | 172 | 2016 |
| GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways E López-Isac, M Acosta-Herrera, M Kerick, S Assassi, AT Satpathy, ... Nature communications 10 (1), 4955, 2019 | 167 | 2019 |
| Determinant spreading: lessons from animal models and human disease J McCluskey, AD Farris, CL Keech, AW Purcell, M Rischmueller, ... Immunological reviews 164 (1), 209-229, 1998 | 149 | 1998 |
| Primary Sjögren's syndrome M Rischmueller, J Tieu, S Lester Best practice & research Clinical rheumatology 30 (1), 189-220, 2016 | 141 | 2016 |
| A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis Y Hao, V Thakkar, W Stevens, K Morrisroe, D Prior, C Rabusa, P Youssef, ... Arthritis research & therapy 17, 1-11, 2015 | 131 | 2015 |
| Interpretation of an extended autoantibody profile in a well‐characterized Australian systemic sclerosis (scleroderma) cohort using principal components analysis KA Patterson, PJ Roberts‐Thomson, S Lester, JA Tan, P Hakendorf, ... Arthritis & Rheumatology 67 (12), 3234-3244, 2015 | 127 | 2015 |
| Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody M Singh, KJL Jackson, JJ Wang, P Schofield, MA Field, D Koppstein, ... Cell 180 (5), 878-894. e19, 2020 | 123 | 2020 |
| Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis TP Gordon, AI Bolstad, M Rischmueller, R Jonsson, SA Waterman Autoimmunity 34 (2), 123-132, 2001 | 120 | 2001 |
| Cerebral white matter lesions in primary Sjögren's syndrome: a controlled study. T Coates, JP Slavotinek, M Rischmueller, D Schultz, C Anderson, ... The Journal of rheumatology 26 (6), 1301-1305, 1999 | 111 | 1999 |
